Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies
The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.
Antibody Therapeutics | 06/04/2026 | By News Bureau
US-based biotechnology company Kaigene has signed an exclusive global licensing agreement with South Korean biopharmaceutical giant Celltrion to develop and commercialise two of its nonclinical-stage antibody assets, KG006 and KG002.
Antibody Therapeutics | 04/11/2025 | By Dineshwori | 706
Harbour BioMed Names Yajie Li as Chief Medical Officer
As Chief Medical Officer (CMO), Yajie Li will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.
Antibody Therapeutics | 25/08/2025 | By Dineshwori | 159
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy